Literature DB >> 12132786

Detection of Helicobacter pylori specific DNA in human atheromatous coronary arteries and its association to prior myocardial infarction and unstable angina.

M Kowalski1, W Rees, P C Konturek, R Grove, T Scheffold, H Meixner, M Brunec, N Franz, J W Konturek, P Pieniazek, E G Hahn, S J Konturek, J Thale, H Warnecke.   

Abstract

BACKGROUND: Chronic infections have been proposed to play a role in the aetiology or progression of atherosclerotic plaques. Increased risk of coronary artery disease has been suggested in patients seropositive for Helicobacter pylori. AIM: To analyse coronary specimens in patients with severe (coronary artery disease) for Helicobacter pylori specific DNA. PATIENTS AND METHODS: Atherosclerotic plaques were obtained in 46 consecutive patients (9 female, 37 male, mean age 62.7+/-9.17 years) during coronary bypass procedures. Serum was analysed for IgG -/cagA-antibodies specific for Helicobacter pylori. Polymerase chain reaction and sequence analysis were used to identify bacterial DNA. Coronary artery biopsies from 19 autopsies without coronary artery disease were examined as a control group.
RESULTS: Of the 46 coronary artery disease patients, 32 (69.6%) were Helicobacter pylori seropositive. Positive results for Helicobacter pylori DNA showed 18 seropositive and 4 seronegative (with anamnesis of eradication therapy). A total of 22 patients (47.8%) of the coronary artery disease group but none of controls revealed positive DNA. In the coronary artery disease group, a correlation between DNA presence and prior myocardial infarction (p=0.008) and unstable angina (p<0.001) was found.
CONCLUSION: Identification of DNA in atherosclerotic plaques of patients with severe coronary artery disease supports the hypothesis that Helicobacter pylori infection may influence the development of atherosclerosis. Our results may indicate an direct involvement of Helicobacter pylori in the progression and instability of plaques in these patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12132786     DOI: 10.1016/s1590-8658(02)80036-6

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  16 in total

Review 1.  In-house nucleic acid amplification assays in research: how much quality control is needed before one can rely upon the results?

Authors:  Petra Apfalter; Udo Reischl; Margaret R Hammerschlag
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

2.  Helicobacter pylori infection and the risk of acute coronary syndrome: a nationwide retrospective cohort study.

Authors:  C-Y Lai; T-Y Yang; C-L Lin; C-H Kao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-07-26       Impact factor: 3.267

Review 3.  Role of Helicobacter pylori infection in pathogenesis of atherosclerosis.

Authors:  Rajesh Vijayvergiya; Ramalingam Vadivelu
Journal:  World J Cardiol       Date:  2015-03-26

Review 4.  Helicobacter pylori: Does it add to risk of coronary artery disease.

Authors:  Vishal Sharma; Amitesh Aggarwal
Journal:  World J Cardiol       Date:  2015-01-26

Review 5.  Helicobacter pylori infection and atherosclerosis: is there a causal relationship?

Authors:  Z Xu; J Li; H Wang; G Xu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-07-27       Impact factor: 3.267

6.  A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis.

Authors:  Lutz Hamann; Abuzeid Gomma; Nicolas W J Schröder; Cordula Stamme; Christiane Glaeser; Susanne Schulz; Michael Gross; Stefan D Anker; Kim Fox; Ralf R Schumann
Journal:  J Mol Med (Berl)       Date:  2005-05-04       Impact factor: 4.599

7.  Helicobacter pylori vs coronary heart disease - searching for connections.

Authors:  Magdalena Chmiela; Adrian Gajewski; Karolina Rudnicka
Journal:  World J Cardiol       Date:  2015-04-26

Review 8.  Can infections cause Alzheimer's disease?

Authors:  Francis Mawanda; Robert Wallace
Journal:  Epidemiol Rev       Date:  2013-01-24       Impact factor: 6.222

9.  Prevalence of Helicobacter pylori, cytomegalovirus, and Chlamydia pneumoniae immunoglobulin seropositivity in coronary artery disease patients and normal individuals in North Indian population.

Authors:  Rohit Tewari; Vs Nijhawan; Mn Mishra; Puja Dudeja; Tk Salopal
Journal:  Med J Armed Forces India       Date:  2012-01-18

Review 10.  Metabolic consequences of Helicobacter pylori infection and eradication.

Authors:  György Miklós Buzás
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.